About this trial
In recent years, research on the effectiveness of transcranial magnetic stimulation (TMS) in patients with treatment-resistant depression (RTD) has been steadily increasing. The aim of this study was to examine the effectiveness of accelerated unilateral application of two different forms of theta burst stimulation (TBU), a variation of repetitive TMU (rTMS)-intermittent TBU (iTBU) and continuous TBU (cTBU)-in TDD patients. The study aimed to compare the advantages of iTBU and cTBU protocols on depression, suicidal thoughts, anxiety levels, sleep disturbances, cognitive performance, and overall functioning following a two-week intensive treatment period and a 12-week follow-up period.
Eligibility criteria
Qualifiers
18 to 65 years old
Patients diagnosed with Major Depressive Disorder according to DSM 5 and the severity of their illness
Scoring 7 points or more on the Maudsley staging method
Having depression unresponsive to 2 different antidepressants
Disqualifiers
Diagnosed with a neurological or metabolic disease that affects cognitive functions (Systemic diseases such as diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic renal failure, Parkinson's disease, multiple sclerosis, polyneuropathy, inflammatory rheumatologic disease and malignancies)
Having a foreign body such as a pacemaker, intracranial implant that can magnetically interact
Hearing and visual impairments that prevent communication
Unstable or acute medical conditions
Trial design
Treatments tested in this trial
- Transcranial Magnetic Stimulation with figure-eight coil
- Transcranial Magnetic Stimulation with figure-eight coil